Targeting molecular resistance in castration-resistant prostate cancer

Overview of attention for article published in BMC Medicine, September 2015

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (70th percentile)

Mentioned by

policy: 1 policy source

twitter: 2 X users

Citations

dimensions_citation: 54 Dimensions

Readers on

mendeley: 88 Mendeley

Summary Policy documents X Dimensions citations

So far, Dimensions has found 54 publications that cite this research output.

54

The most recent citing publications are shown below. View all 54 publications that cite this research output on Dimensions.

Aryl hydrocarbon receptor as a drug target in advanced prostate cancer therapy – obstacles and perspectives

Article in Transcription (March 2024)

Intratumoral Restoration of miR-137 Plus Cholesterol Favors Homeostasis of the miR-137/Coactivator p160/AR Axis and Negatively Modulates Tumor Progression in Advanced Prostate Cancer

Article in International Journal of Molecular Sciences (June 2023)

TBX2 driven switch from Androgen Receptor to Glucocorticoid Receptor signaling confers therapeutic resistance in Prostate Cancer

Preprint in bioRxiv (May 2023)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.